KRYSTAL-1: Activity and safety of adagrasib (MRTX849) in patients with advanced solid tumors harboring a KRAS(G12C) mutation Meeting Abstract


Authors: Pant, S.; Yaeger, R.; Spira, A. I.; Pelster, M.; Sabari, J. K.; Hafez, N.; Barve, M. A.; Velastegui, K.; Yan, X. H.; Der-Torossian, H.; Bekaii-Saab, T. S.
Abstract Title: KRYSTAL-1: Activity and safety of adagrasib (MRTX849) in patients with advanced solid tumors harboring a KRAS(G12C) mutation
Meeting Title: 2023 ASCO Monthly Plenary Series: April Session
Journal Title: Journal of Clinical Oncology
Volume: 41
Issue: 36 Suppl.
Meeting Dates: 2023 Apr 20
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2023-11-03
Language: English
ACCESSION: WOS:001094769600005
PROVIDER: wos
DOI: 10.1200/JCO.2023.41.36_suppl.425082
Notes: Meeting Abstract: 425082 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Rona Denit Yaeger
    315 Yaeger